Please provide your email address to receive an email when new articles are posted on . Untreated hyperthyroidism in pregnancy places the mother and child at an elevated risk for a number of adverse ...

SAN DIEGO — New findings out of Japan add to increasing evidence that the use of methimazole to treat the hyperthyroidism of Graves' disease in early pregnancy significantly increases the risk for ...

April 21, 2010 — The US Food and Drug Administration (FDA) has added a boxed warning to the drug label for propylthiouracil about reports of severe liver injury and acute liver failure, in some cases ...

Agranulocytosis is the most severe adverse effect of antithyroid drug therapy. The findings of a novel study from Japan suggest that this complication occurs more frequently if higher rather than ...

SINCE the introduction of antithyroid-drug therapy for the treatment of hyperthyroidism by Astwood 1 in 1943 a variety of therapeutic programs and specific drugs have been proposed. However, in the ...

Considering this estimate, we suggest that propylthiouracil should no longer be used as first-line treatment for Graves' disease in children. Alternative treatments should be considered for children ...

Pregnant women who are exposed to antithyroid drugs (ATDs) during the first trimester are associated with increased risk for congenital malformations, reveals a new study. The risk is much higher ...

(Boston)—A thyroid storm is characterized by high-circulating thyroid hormones (severe hyperthyroidism) that leads to life-threatening acute end-organ damage, including neurologic dysfunction, ...

Propylthiouracil therapy should be discontinued in children in favor of alternative approaches, say US researchers, after a systematic and comparative evaluation of the adverse events associated with ...

A pill used for thyroid disease can cause fatal liver failure in children and should no longer be used to treat them, two doctors warn. Subscribe to read this story ad-free Get unlimited access to ...

Please provide your email address to receive an email when new articles are posted on . New data suggest that the timing of antithyroid treatment-induced myeloperoxidase antineutrophil cytoplasmic ...